Health-related quality of life in adults with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab
Max S. Topp(Universitätsklinikum Würzburg), Andre C. Schuh(University of Toronto), Qui Tran(Amgen (United States)), Janet Franklin(Children's Hospital of Los Angeles), Zachary Zimmerman(Amgen (United States)), Johan Maertens(Unknown), Ze Cong(Amgen (United States)), Hervé Dombret(University of London Institute in Paris), Paul Cannell, Anthony S. Stein(University of Hohenheim)
Cited by 48
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k